Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase 1 8Phase NA 4Phase 3 4Phase 1/2 2Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 19INDUSTRY 15OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Lymphoma 4Colorectal Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myeloid, Acute 2Leukemia 2Xerostomia 1Warts 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Tongue Neoplasms 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Stomach Neoplasms 1Sezary Syndrome 1Seminoma 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Salivary Gland Neoplasms 1Recurrent Squamous Cell Lung Carcinoma 1Recurrence 1Prostatic Neoplasms 1Previously Treated Non-Small Cell Lung Cancer 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Pain 1

Interventions

interferon gamma-1b 1interferon gamma, Cys(-3), Tyr(-2), Cys(-1)- 1etoposide phosphate 1aldesleukin 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Interleukin-2 1Interferon-gamma 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Cytarabine 1Cyclosporins 1Cyclosporine 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × NETWORK × Recurrence × Clear all
NCT00070187 2013-10-17

Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma

Children's Oncology Group

Phase 2/3 Completed
24 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡